Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease

Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease

Identifying accurate biomarkers of cognitive decline is essential for advancing early diagnosis and prevention therapies in Alzheimer's disease. The Alzheimer's disease DREAM Challenge was designed as a computational crowdsourced project to benchmark the current state-of-the-art in predict...

Full description

Bibliographic Details
Main Authors:	Allen, G, Amoroso, N, Anghel, C, Lovestone, S
Format:	Journal article
Language:	English
Published:	Elsevier 2016

Similar Items

Structural Network Efficiency Predicts Resilience to Cognitive Decline in Elderly at Risk for Alzheimer’s Disease
by: Florian U. Fischer, et al.
Published: (2021-02-01)

Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variation.
by: Holmes, C, et al.
Published: (2005)

Cognitive declines precede and predict functional declines in aging and Alzheimer's disease.
by: Laura B Zahodne, et al.
Published: (2013-01-01)

Postmortem serotoninergic correlates of cognitive decline in Alzheimer's disease.
by: Lai, M, et al.
Published: (2002)

Cognitive resilience and severe Alzheimer’s disease neuropathology
by: Narges Ahangari, et al.
Published: (2023-01-01)

Homocysteine as a predictor of cognitive decline in Alzheimer's disease
by: Oulhaj, A, et al.
Published: (2010)

Homocysteine as a predictor of cognitive decline in Alzheimer's disease.
by: Oulhaj, A, et al.
Published: (2010)

Impact of atrial fibrillation on the cognitive decline in Alzheimer’s disease
by: Taizen Nakase, et al.
Published: (2023-01-01)

The Role of Leptin and Adiponectin in Obesity-Associated Cognitive Decline and Alzheimer’s Disease
by: Leticia Forny-Germano, et al.
Published: (2019-01-01)

Air pollution is associated with faster cognitive decline in Alzheimer's disease
by: Young‐gun Lee, et al.
Published: (2023-06-01)

Predictive Factors of Rapid Cognitive Decline in Patients with Alzheimer Disease
by: Coralie Barbe, et al.
Published: (2016-12-01)

Traditional used Plants against Cognitive Decline and Alzheimer Disease
by: Gunter Peter Eckert
Published: (2010-12-01)

Subjective cognitive decline: The first clinical manifestation of Alzheimer's disease?
by: Adalberto Studart Neto, et al.

Repurposing verapamil for prevention of cognitive decline in sporadic Alzheimer’s disease
by: Heba A Ahmed, et al.
Published: (2022-01-01)

The Alzheimer’s Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer’s disease
by: Jessica B. Langbaum, et al.
Published: (2020-05-01)

Neuronal-Derived EV Biomarkers Track Cognitive Decline in Alzheimer’s Disease
by: Erden Eren, et al.
Published: (2022-01-01)

Temporal Change of Cognitive Decline in Alzheimer’s Disease: The Results of Turquoise Alzheimer’s Working Group
by: Nilgün Çınar, et al.
Published: (2014-06-01)

Association of Plasma Transferrin With Cognitive Decline in Patients With Mild Cognitive Impairment and Alzheimer’s Disease
by: Jingjing Guan, et al.
Published: (2020-03-01)

Epigenetic Mechanisms in Memory and Cognitive Decline Associated with Aging and Alzheimer’s Disease
by: Sabyasachi Maity, et al.
Published: (2021-11-01)

Comprehensive Review of Nutraceuticals against Cognitive Decline Associated with Alzheimer’s Disease
by: Edwin E. Reza-Zaldívar, et al.
Published: (2023-09-01)

Progress in blood biomarkers of subjective cognitive decline in preclinical Alzheimer's disease
by: Xianfeng Yu, et al.
Published: (2023-03-01)

Early detection of cognitive decline in Alzheimer’s disease using eye tracking
by: Shin-ichi Tokushige, et al.
Published: (2023-03-01)

The effects of time-restricted eating on sleep, cognitive decline, and Alzheimer's disease
by: Armin Ezzati, et al.
Published: (2023-01-01)

Abnormal Dynamic Functional Networks in Subjective Cognitive Decline and Alzheimer's Disease
by: Jue Wang, et al.
Published: (2022-05-01)

Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease
by: Xiaoqi Wang, et al.
Published: (2020-09-01)

Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease
by: Hákon Valur Dansson, et al.
Published: (2021-09-01)

Aspirin using was associated with slower cognitive decline in patients with Alzheimer's disease.
by: Jinyan Weng, et al.
Published: (2021-01-01)

Glia and zinc in ageing and Alzheimer’s disease: A mechanism for cognitive decline?
by: Sara eHancock, et al.
Published: (2014-06-01)

Default Mode Network Complexity and Cognitive Decline in Mild Alzheimer’s Disease
by: Matthias Grieder, et al.
Published: (2018-10-01)

Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment
by: Pia Kivisäkk, et al.
Published: (2023-03-01)

Objective subtle cognitive decline and plasma phosphorylated tau181: Early markers of Alzheimer's disease‐related declines
by: Kelsey R. Thomas, et al.
Published: (2021-01-01)

Depressive symptoms and olfactory function in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer's disease
by: C. Bergmann, et al.
Published: (2021-06-01)

Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum
by: Mark A. Dubbelman, et al.
Published: (2020-10-01)

APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
by: Martins, C, et al.
Published: (2005)

Cognitive decline in patients with Alzheimer's disease, vascular dementia and senile dementia of Lewy body type.
by: Ballard, C, et al.
Published: (1996)

Use it or lose it! Cognitive activity as a protective factor for cognitive decline associated with Alzheimer’s disease
by: Panagiota Mistridis, et al.
Published: (2017-03-01)

Resting state EEG biomarkers of cognitive decline associated with Alzheimer's disease and mild cognitive impairment.
by: Amir H Meghdadi, et al.
Published: (2021-01-01)

PSEN1 polymorphisms alter the rate of cognitive decline in sporadic Alzheimer's disease patients.
by: Belbin, O, et al.
Published: (2009)

Microanatomical correlates of cognitive ability and decline: normal ageing, MCI, and Alzheimer's disease.
by: Chance, SA, et al.
Published: (2011)

Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer's disease.
by: Combrinck, M, et al.
Published: (2006)